CSL - Pre Tax Profit

Stock Price
136.58
Daily Change
-1.42 -1.03%
Monthly
-10.89%
Yearly
-46.51%
Q1 Forecast
138.07

CSL reported $2.61B in Pre-Tax Profit for its fiscal semester ending in December of 2025.





Pre Tax Profit Change Date
Alterity Therapeutics Limited AUD -4.74M 3.53M Dec/2024
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD -25.75M 6.22M Sep/2025
Bio Path USD -4.6M 1.74M Jun/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
CSL USD 2.61B 1.21B Dec/2025
Curis USD -13.99M 7.38M Jun/2025
Esperion Therapeutics USD 63.67M 95M Dec/2025
Immunic USD -21.38M 8.2M Jun/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 22.51M 30.74M Sep/2024
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
TherapeuticsMD USD -1.05M 241K Jun/2024